Anybody watching Tap trading over the last two years would have seen the share price driven down by a certain two. The only ones not to see this was As#c when called upon to investigate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025